Abstract
Summary
According to our LPI (LP Information) latest study, the global Generic Drugs market size was valued at US$ 306650 million in 2023. With growing demand in downstream market, the Generic Drugs is forecast to a readjusted size of US$ 546690 million by 2030 with a CAGR of 8.6% during review period.
The research report highlights the growth potential of the global Generic Drugs market. Generic Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Generic Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Generic Drugs market.
A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.
Market competition is not intense. Teva, Novartis – Sandoz, Mylan, Sun Pharmaceutical and Aspen are the leaders of the industry, with about 19% market shares.
North America is the largest consumption place, with a consumption market share nearly 44%. Following North America, Europe is the second largest consumption place with the consumption market share of 18%.
Key Features:
The report on Generic Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Generic Drugs market. It may include historical data, market segmentation by Type (e.g., Oral, Injection), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Generic Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Generic Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Generic Drugs industry. This include advancements in Generic Drugs technology, Generic Drugs new entrants, Generic Drugs new investment, and other innovations that are shaping the future of Generic Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Generic Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Generic Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Generic Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Generic Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Generic Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Generic Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Generic Drugs market.
Market Segmentation:
Generic Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Oral
Injection
Other
Segmentation by application
Hospital Pharmacy
Retail Pharmacy
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Teva
Novartis
Viatris
Sun Pharmaceutical
Aspen Pharmacare
Fresenius Kabi
Sanofi
Aurobindo
Lupin
Dr. Reddy's
Apotex
Cipla
ENDO
Stada Arzneimittel
Bausch Health
Hikma
Torrent
Glenmark
Piramal Pharma
Sawai Pharmaceutical
The research report highlights the growth potential of the global Generic Drugs market. Generic Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Generic Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Generic Drugs market.
A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.
Market competition is not intense. Teva, Novartis – Sandoz, Mylan, Sun Pharmaceutical and Aspen are the leaders of the industry, with about 19% market shares.
North America is the largest consumption place, with a consumption market share nearly 44%. Following North America, Europe is the second largest consumption place with the consumption market share of 18%.
Key Features:
The report on Generic Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Generic Drugs market. It may include historical data, market segmentation by Type (e.g., Oral, Injection), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Generic Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Generic Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Generic Drugs industry. This include advancements in Generic Drugs technology, Generic Drugs new entrants, Generic Drugs new investment, and other innovations that are shaping the future of Generic Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Generic Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Generic Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Generic Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Generic Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Generic Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Generic Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Generic Drugs market.
Market Segmentation:
Generic Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Oral
Injection
Other
Segmentation by application
Hospital Pharmacy
Retail Pharmacy
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Teva
Novartis
Viatris
Sun Pharmaceutical
Aspen Pharmacare
Fresenius Kabi
Sanofi
Aurobindo
Lupin
Dr. Reddy's
Apotex
Cipla
ENDO
Stada Arzneimittel
Bausch Health
Hikma
Torrent
Glenmark
Piramal Pharma
Sawai Pharmaceutical
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Generic Drugs Market Size 2019-2030
2.1.2 Generic Drugs Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Generic Drugs Segment by Type
2.2.1 Oral
2.2.2 Injection
2.2.3 Other
2.3 Generic Drugs Market Size by Type
2.3.1 Generic Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Generic Drugs Market Size Market Share by Type (2019-2024)
2.4 Generic Drugs Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Other
2.5 Generic Drugs Market Size by Application
2.5.1 Generic Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Generic Drugs Market Size Market Share by Application (2019-2024)
3 Generic Drugs Market Size by Player
3.1 Generic Drugs Market Size Market Share by Players
3.1.1 Global Generic Drugs Revenue by Players (2019-2024)
3.1.2 Global Generic Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Generic Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Generic Drugs by Regions
4.1 Generic Drugs Market Size by Regions (2019-2024)
4.2 Americas Generic Drugs Market Size Growth (2019-2024)
4.3 APAC Generic Drugs Market Size Growth (2019-2024)
4.4 Europe Generic Drugs Market Size Growth (2019-2024)
4.5 Middle East & Africa Generic Drugs Market Size Growth (2019-2024)
5 Americas
5.1 Americas Generic Drugs Market Size by Country (2019-2024)
5.2 Americas Generic Drugs Market Size by Type (2019-2024)
5.3 Americas Generic Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Generic Drugs Market Size by Region (2019-2024)
6.2 APAC Generic Drugs Market Size by Type (2019-2024)
6.3 APAC Generic Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Generic Drugs by Country (2019-2024)
7.2 Europe Generic Drugs Market Size by Type (2019-2024)
7.3 Europe Generic Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Generic Drugs by Region (2019-2024)
8.2 Middle East & Africa Generic Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Generic Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Generic Drugs Market Forecast
10.1 Global Generic Drugs Forecast by Regions (2025-2030)
10.1.1 Global Generic Drugs Forecast by Regions (2025-2030)
10.1.2 Americas Generic Drugs Forecast
10.1.3 APAC Generic Drugs Forecast
10.1.4 Europe Generic Drugs Forecast
10.1.5 Middle East & Africa Generic Drugs Forecast
10.2 Americas Generic Drugs Forecast by Country (2025-2030)
10.2.1 United States Generic Drugs Market Forecast
10.2.2 Canada Generic Drugs Market Forecast
10.2.3 Mexico Generic Drugs Market Forecast
10.2.4 Brazil Generic Drugs Market Forecast
10.3 APAC Generic Drugs Forecast by Region (2025-2030)
10.3.1 China Generic Drugs Market Forecast
10.3.2 Japan Generic Drugs Market Forecast
10.3.3 Korea Generic Drugs Market Forecast
10.3.4 Southeast Asia Generic Drugs Market Forecast
10.3.5 India Generic Drugs Market Forecast
10.3.6 Australia Generic Drugs Market Forecast
10.4 Europe Generic Drugs Forecast by Country (2025-2030)
10.4.1 Germany Generic Drugs Market Forecast
10.4.2 France Generic Drugs Market Forecast
10.4.3 UK Generic Drugs Market Forecast
10.4.4 Italy Generic Drugs Market Forecast
10.4.5 Russia Generic Drugs Market Forecast
10.5 Middle East & Africa Generic Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Generic Drugs Market Forecast
10.5.2 South Africa Generic Drugs Market Forecast
10.5.3 Israel Generic Drugs Market Forecast
10.5.4 Turkey Generic Drugs Market Forecast
10.5.5 GCC Countries Generic Drugs Market Forecast
10.6 Global Generic Drugs Forecast by Type (2025-2030)
10.7 Global Generic Drugs Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Teva
11.1.1 Teva Company Information
11.1.2 Teva Generic Drugs Product Offered
11.1.3 Teva Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Teva Main Business Overview
11.1.5 Teva Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Generic Drugs Product Offered
11.2.3 Novartis Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Viatris
11.3.1 Viatris Company Information
11.3.2 Viatris Generic Drugs Product Offered
11.3.3 Viatris Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Viatris Main Business Overview
11.3.5 Viatris Latest Developments
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Information
11.4.2 Sun Pharmaceutical Generic Drugs Product Offered
11.4.3 Sun Pharmaceutical Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Sun Pharmaceutical Main Business Overview
11.4.5 Sun Pharmaceutical Latest Developments
11.5 Aspen Pharmacare
11.5.1 Aspen Pharmacare Company Information
11.5.2 Aspen Pharmacare Generic Drugs Product Offered
11.5.3 Aspen Pharmacare Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Aspen Pharmacare Main Business Overview
11.5.5 Aspen Pharmacare Latest Developments
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Information
11.6.2 Fresenius Kabi Generic Drugs Product Offered
11.6.3 Fresenius Kabi Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Fresenius Kabi Main Business Overview
11.6.5 Fresenius Kabi Latest Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Generic Drugs Product Offered
11.7.3 Sanofi Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Sanofi Main Business Overview
11.7.5 Sanofi Latest Developments
11.8 Aurobindo
11.8.1 Aurobindo Company Information
11.8.2 Aurobindo Generic Drugs Product Offered
11.8.3 Aurobindo Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Aurobindo Main Business Overview
11.8.5 Aurobindo Latest Developments
11.9 Lupin
11.9.1 Lupin Company Information
11.9.2 Lupin Generic Drugs Product Offered
11.9.3 Lupin Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Lupin Main Business Overview
11.9.5 Lupin Latest Developments
11.10 Dr. Reddy's
11.10.1 Dr. Reddy's Company Information
11.10.2 Dr. Reddy's Generic Drugs Product Offered
11.10.3 Dr. Reddy's Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Dr. Reddy's Main Business Overview
11.10.5 Dr. Reddy's Latest Developments
11.11 Apotex
11.11.1 Apotex Company Information
11.11.2 Apotex Generic Drugs Product Offered
11.11.3 Apotex Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Apotex Main Business Overview
11.11.5 Apotex Latest Developments
11.12 Cipla
11.12.1 Cipla Company Information
11.12.2 Cipla Generic Drugs Product Offered
11.12.3 Cipla Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Cipla Main Business Overview
11.12.5 Cipla Latest Developments
11.13 ENDO
11.13.1 ENDO Company Information
11.13.2 ENDO Generic Drugs Product Offered
11.13.3 ENDO Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 ENDO Main Business Overview
11.13.5 ENDO Latest Developments
11.14 Stada Arzneimittel
11.14.1 Stada Arzneimittel Company Information
11.14.2 Stada Arzneimittel Generic Drugs Product Offered
11.14.3 Stada Arzneimittel Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Stada Arzneimittel Main Business Overview
11.14.5 Stada Arzneimittel Latest Developments
11.15 Bausch Health
11.15.1 Bausch Health Company Information
11.15.2 Bausch Health Generic Drugs Product Offered
11.15.3 Bausch Health Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Bausch Health Main Business Overview
11.15.5 Bausch Health Latest Developments
11.16 Hikma
11.16.1 Hikma Company Information
11.16.2 Hikma Generic Drugs Product Offered
11.16.3 Hikma Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Hikma Main Business Overview
11.16.5 Hikma Latest Developments
11.17 Torrent
11.17.1 Torrent Company Information
11.17.2 Torrent Generic Drugs Product Offered
11.17.3 Torrent Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Torrent Main Business Overview
11.17.5 Torrent Latest Developments
11.18 Glenmark
11.18.1 Glenmark Company Information
11.18.2 Glenmark Generic Drugs Product Offered
11.18.3 Glenmark Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Glenmark Main Business Overview
11.18.5 Glenmark Latest Developments
11.19 Piramal Pharma
11.19.1 Piramal Pharma Company Information
11.19.2 Piramal Pharma Generic Drugs Product Offered
11.19.3 Piramal Pharma Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Piramal Pharma Main Business Overview
11.19.5 Piramal Pharma Latest Developments
11.20 Sawai Pharmaceutical
11.20.1 Sawai Pharmaceutical Company Information
11.20.2 Sawai Pharmaceutical Generic Drugs Product Offered
11.20.3 Sawai Pharmaceutical Generic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Sawai Pharmaceutical Main Business Overview
11.20.5 Sawai Pharmaceutical Latest Developments
12 Research Findings and Conclusion